Search results

Articles (5)

Journals (0)

1-5 of 5 results for second-line biological disease-modifying antirheumatic drugs

Sort by:

Relevance

Select all

Sort by:

Relevance

Open access

Research article

First published 2021

Factors affecting drug survival of an alternative TNF inhibitor and secukinumab in patients with ankylosing spondylitis switching from the first TNF inhibitor

Oh Chan Kwon, Jung Hwan Park, Min-Chan Park

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2023

Drug switching in axial spondyloarthritis patients in Germany – a social listening analysis

Maria Kahn, Steffeni Papukchieva, Axel Fehr [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2022

Comparison of the efficacy and risk of discontinuation between non-TNF-targeted treatment and a second TNF inhibitor in patients with rheumatoid arthritis after first TNF inhibitor failure

Dong-Jin Park, Sung-Eun Choi, Ji-Hyoun Kang [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2026

Persistence of IL-17 and TNF inhibitors following initial TNF inhibitor use in axial spondyloarthritis: a nationwide retrospective cohort study

Yu-Seon Jung, Soo-Kyung Cho, Se Rim Choi [...]

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Review article

First published 2000-6

Treatment Options for Rheumatoid Arthritis: Celecoxib,Leflunomide,Etanercept,and Infliximab

Brigitte T Luong, Barbara S Chong, Dionne M Lowder

Annals of Pharmacotherapy